| API Access | |

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure was processed by Pulse News Wire. It represents a primary source document for Japanese equity sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Medical Data Vision Co.,Ltd. Board Supports Tender Offer, Recommends Shareholders Tender

Source disclosure: February 27, 2026, 15:30 JST Medical Data Vision Co.,Ltd. [3902.T] TOKYO, Feb 27 (Pulse News Wire) – Medical Data Vision Co.,Ltd. (3902.T) announced that its board has expressed support for the management buyout by at ¥1,310 per unit. The board recommends that shareholders tender their shares. An independent special committee established to review the transaction concluded that the terms are fair to shareholders. AI-translated content. 🟢 Confidence: High S

Source disclosure: February 27, 2026, 15:30 JST

Medical Data Vision Co.,Ltd. [3902.T]

TOKYO, Feb 27 (Pulse News Wire) – Medical Data Vision Co.,Ltd. (3902.T) announced that its board has expressed support for the management buyout by at ¥1,310 per unit.

The board recommends that shareholders tender their shares. An independent special committee established to review the transaction concluded that the terms are fair to shareholders.

AI-translated content. 🟢 Confidence: High See terms • Original filing

💬 Help us improve translation quality

Notice any errors in this article? Let us know with one click.

🎁 Report 3+ errors with your email and get a free month of premium access